tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY

Compare Santen Pharmaceutical Co (SNPHY) vs. Competitors

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santen Pharmaceutical Co
$11.00
$3.41B
16.26
9.29%
Bristol-Myers Squibb
$57.48
$117.06B
15.61
-4.87%
8 Buy
11 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
$51.84
$104.09B
13.19
31.54%
1 Buy
3 Hold
1 Sell
Hold
Grifols SA
$8.78
$6.25B
13.91
-4.05%
Sanofi
$44.60
$108.56B
-31.42
-22.82%
1 Buy
2 Hold
0 Sell
Moderate Buy
AstraZeneca
13896.00 p
£215.50B
28.13
17.68%
13 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SNPHY
Santen Pharmaceutical Co
10.59
0.91
9.38%
BMY
Bristol-Myers Squibb
57.48
-0.65
-1.12%
GSK
GlaxoSmithKline
51.84
14.10
37.37%
GRFS
Grifols SA
7.58
-0.11
-1.43%
SNY
Sanofi
44.60
-10.54
-19.12%
GB:AZN
AstraZeneca
13,896.00
2,486.84
21.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts